Sysmex Europe

Sentimag® - Magseed® in breast cancer

In recent years, advancements in medical practices have offered more women diagnosed with breast cancer the opportunity to receive breast-conserving and lymph node-sparing surgery. At any stage, the target is to de-escalate the surgical radicality.

To ensure both oncologic safety and patient comfort, reliable marking of lesions and target lymph nodes is a prerequisite. However, many tissue markers encounter significant challenges, including:

  • unreliable detectability due to migration or low visibility in imaging
  • radiation exposure
  • not always suitable for long-term placement
  • not always suitable for each tissue type

As a result, patients can experience discomfort, such as unnecessary anxiety, physical pain and a suboptimal cosmetic outcome.

The Magseed® marker has been specifically designed to overcome the challenges of other clip, reflector, tag, radioseed and wire markers. It enables a flexible patient treatment pathway – from placement of the marker until the day of surgery. Magseed® promotes high oncologic safety, accurate tissue localisations and improved patient satisfaction, preventing unnecessary surgery and helping to reduce the extent of the required ones.

Magseed® is used alongside the Sentimag® system, a sensitive magnetic detector that locates the seed. The marker is deployed under ultrasound or X-ray guidance any time before surgery. Once in the operating room, the surgeon then uses the Sentimag® system’s probe to precisely locate the Magseed®, and thereby the lesion or lymph node in which the Magseed® has been placed.


Endomag®, Sentimag® and Magseed® are registered European Union trademarks of Endomagnetics Ltd

Magtrace® is a registered trademark of Endomagnetics Ltd in the United Kingdom

More details

Magseed® – benefits for clinicians and patients

  • Designed with the patient in mind – no radioactivity, reduced stress, less pain
  • Placed in any soft tissue – breast lesion, lymph node, etc.
  • Can be implanted for as long as needed – always reliably detectable by Sentimag®
  • Smallest non-radioactive seed – ideal for lymph node placement
  • Decoupling of OR and radiology scheduling
  • Stays securely in place without migration from soft tissue
  • Very low re-excision rate for lesions (11 % averaged over multiple studies)
  • Magseed® has been used in over 65,000 tissue localisations
  • Sentimag® and Magseed® are CE-marked and FDA-cleared for soft tissue

Sysmex Europe SE

Bornbarch 1

22848 Norderstedt


+49 (40) 527 26 0

+49 (40) 527 26 100

Explore more

Copyright © Sysmex Europe SE. All rights reserved.
Customize your experience

We use cookies to enable you to optimally use our Website and to improve our communication with you. We shall take your selection into account and use only the data for which you give us your consent.

* May lead to restrictions in content and in the user experience
Detail about cookies
Essential cookies
These cookies help to make our website usable by enabling basic features such as page navigation and access to secure areas of our website. Our website cannot function properly without these cookies.
Statistics cookies
By collecting information anonymously, these cookies help us to understand how visitors interact with our website. This information enables us to continually improve our platform.
Marketing cookies
are used to track visitors on websites. The intention is to show advertisements that are relevant and appealing to the individual user and are, therefore, valuable to publishers and third-party advertisers.